 |
|
Appropriateness of Rabies Postexposure Prophylaxis Treatment for Animal Exposures
Gregory J. Moran, MD;
David A. Talan, MD;
William Mower, MD, PhD;
Michael Newdow, MD, MPH;
Samuel Ong, MD;
Janet Y. Nakase, MPH;
Robert W. Pinner, MD;
James E. Childs, ScD;
for the Emergency ID Net Study Group
JAMA. 2000;284:1001-1007.
Context Rabies postexposure prophylaxis (RPEP) treatments and associated costs have increased in the United States. The extent to which RPEP use is consistent with guidelines is not well understood.
Objective To characterize animal contacts and determine the frequency and factors associated with inappropriate RPEP use.
Design, Setting, and Patients Prospective case series study of patients presenting with an animal exposure–related complaint from July 1996 to September 1998 at 11 university-affiliated, urban emergency departments (the Emergency ID Net).
Main Outcome Measures Exposure type, circumstances, and RPEP use (appropriateness defined by local public health departments).
Results Of 2030 exposures, 1635 (81%) were to dogs; 268 (13%) to cats; 88 (4%) to rodents/rabbits; 10 (0.5%) to raccoons; 5 (0.2%) to bats; and 24 (1.2%) to other animals. Among those exposed, 136 (6.7%) received RPEP after dog (95), cat (21), raccoon (8), bat (4), or other animal (8) exposures. Use of RPEP varied by site (range, 0%-27.7% of exposures), with most frequent use reported at sites in the eastern United States. Management was considered appropriate in 1857 exposures (91.5%). Use of RPEP was considered inappropriate in 54 cases (40% of those in which it was given), owing to factors including animal availability for observation and exposure in a low-endemicity area. Rabies postexposure prophylaxis was considered inappropriately withheld from 119 cases (6.3% of those not receiving RPEP), often because a domestic animal was unavailable for observation or testing.
Conclusion These results suggest that use of RPEP is often inappropriate. Greater compliance with current guidelines would increase RPEP use. Physician education, improved coordination with public health officials, and clarification of RPEP guidelines could optimize use of this expensive resource.
Author Affiliations: Olive View–University of California, Los Angeles, Medical Center, Sylmar (Drs Moran, Talan, Mower, Newdow, and Ong and Ms Nakase); University of California, Los Angeles, School of Medicine, Los Angeles (Drs Moran, Talan, Mower, Newdow, and Ong and Ms Nakase); and the National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga (Drs Pinner and Childs).
RELATED LETTER
Postexposure Prophylaxis for Rabies
James Ryan and Gregory J. Moran
JAMA. 2000;284(22):2870-2871.
EXTRACT
| FULL TEXT
RELATED ARTICLES
August 23, 2000
JAMA. 2000;284(8):1035-1036.
EXTRACT
| FULL TEXT
Rabies
JAMA. 2000;284(8):1052.
PDF
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
A change in rabies post-exposure treatment guidelines after decision analysis in Israel
Dubnov et al.
Eur J Public Health 2007;17:92-97.
ABSTRACT
| FULL TEXT
Prophylaxis against Rabies
Rupprecht and Gibbons
NEJM 2004;351:2626-2635.
FULL TEXT
Postexposure Prophylaxis for Rabies
Ryan and Moran
JAMA 2000;284:2870-2871.
FULL TEXT
How Well Is Rabies Prophylaxis Used?
JWatch Neurology 2000;2000:12-12.
FULL TEXT
Rabies Postexposure Prophylaxis
JWatch Emergency Med. 2000;2000:9-9.
FULL TEXT
How Well Is Rabies Prophylaxis Used?
JWatch Infect. Diseases 2000;2000:5-5.
FULL TEXT
Rabies Vaccine Often Used Incorrectly
JWatch General 2000;2000:5-5.
FULL TEXT
|
